Clinical Trial Update: A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase pilot study evaluating glutamine PET imaging for head and neck squamous cell carcinoma, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer | EARLY_Phase 1 | Status: TERMINATED